US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist
  • 0.9700
  • -0.0299-2.99%
Close Dec 20 16:00 ET
25.68MMarket Cap-0.38P/E (TTM)

About Akari Therapeutics Company

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.

Company Profile

SymbolAKTX
Company NameAkari Therapeutics
Listing DateJan 31, 2014
Founded2004
CEODr. Samir R. Patel, M.D.
MarketNASDAQ
Employees12
Securities TypeDR
ADS Ratio1.0 : 2000.0
Fiscal Year Ends12-31
Address22 Boston Wharf Road,7th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-929-274-7510
Websitehttp://www.akaritx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Samir R. Patel, M.D.
  • Director, President and Chief Executive Officer
  • 9.81K
  • Dr. John F. Neylan, M.D.
  • Chief Medical Officer
  • --
  • Dr. Miles Nunn
  • Chief Scientific Officer
  • --
  • Dr. Torsten Hombeck, PhD
  • Chief Financial Officer
  • 167.51K
  • Dr. Raymond Prudo-Chlebosz, M.D.
  • Chairman of the Board
  • 113.00K
  • Sandip I. Patel
  • Director
  • --
  • James R. Neal, M.B.A.,M.S.
  • Director
  • --
  • Dr. Hoyoung Huh,M.D.,PhD
  • Director
  • --
  • Robert B. Bazemore, Jr
  • Independent Director
  • --
  • Abizer Gaslightwala
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data